Research ArticleCardiovascular
Selective Kinin Receptor Agonists as Cardioprotective Agents in Myocardial Ischemia and Diabetes
Louis Potier, Ludovic Waeckel, Marie-Pascale Vincent, Catherine Chollet, Fernand Gobeil Jr, Michel Marre, Patrick Bruneval, Christine Richer, Ronan Roussel, François Alhenc-Gelas and Nadine Bouby
Journal of Pharmacology and Experimental Therapeutics July 2013, 346 (1) 23-30; DOI: https://doi.org/10.1124/jpet.113.203927
Louis Potier
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
Ludovic Waeckel
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
Marie-Pascale Vincent
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
Catherine Chollet
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
Fernand Gobeil Jr
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
Michel Marre
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
Patrick Bruneval
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
Christine Richer
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
Ronan Roussel
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
François Alhenc-Gelas
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
Nadine Bouby
INSERM U872, Research Center les Cordeliers, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Pierre et Marie Curie University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Paris Descartes University, Paris, France (L.P., L.W., M.-P.V., C.C., C.R., R.R., F.A.-G., N.B.); Diabetology, Endocrinology, and Nutrition Department, AP-HP, Bichat-Claude Bernard Hospital, Paris, France (L.P., M.M., R.R.); Department of Pharmacology, Sherbrooke University, Sherbrooke, Quebec, Canada (F.G.); Paris Diderot University, Paris, France (M.M., R.R.); INSERM U695, Paris, France (M.M., R.R.); Department of Pathology, Georges Pompidou European Hospital, Paris, France (P.B.)
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleCardiovascular
Kinin Receptor Agonists and Cardioprotection
Louis Potier, Ludovic Waeckel, Marie-Pascale Vincent, Catherine Chollet, Fernand Gobeil, Michel Marre, Patrick Bruneval, Christine Richer, Ronan Roussel, François Alhenc-Gelas and Nadine Bouby
Journal of Pharmacology and Experimental Therapeutics July 1, 2013, 346 (1) 23-30; DOI: https://doi.org/10.1124/jpet.113.203927
Research ArticleCardiovascular
Kinin Receptor Agonists and Cardioprotection
Louis Potier, Ludovic Waeckel, Marie-Pascale Vincent, Catherine Chollet, Fernand Gobeil, Michel Marre, Patrick Bruneval, Christine Richer, Ronan Roussel, François Alhenc-Gelas and Nadine Bouby
Journal of Pharmacology and Experimental Therapeutics July 1, 2013, 346 (1) 23-30; DOI: https://doi.org/10.1124/jpet.113.203927
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement